The healthcare sector is undergoing transformative changes powered by science, technology, and innovation, leading to healthier and longer lives. As an industry leader, Zhaotai Group is advancing from traditional healthcare models to a technology-driven approach. Our focus is on pioneering technologies like AAV gene editing therapies, drug research and development, iPS multipotent stem cell therapies, and innovative German BOT pharmaceuticals. Through close collaboration with top global partners, we explore new opportunities for innovation and partnership.
In areas such as biotechnology, elder care, and health management, we leverage our expertise and foster international partnerships to drive comprehensive development in healthcare. We are committed to supporting the growth and advancement of China’s healthcare industry and look forward to expanding our role in the sector’s future.
Biotechnology
Baoming (Beijing) Biotechnology Co., Ltd., a subsidiary of Zhaotai Group, possesses research and innovation capabilities in the field of biomedicine and also provides advanced technical products for the data-driven health sector.
Community Elderly Care
Beijing Zhaohe Jiatai Health Management Co., Ltd., a subsidiary of Zhaotai Group, has established a one-stop, multi-level, continuous, and full-cycle digital service system, aiming to create a precise and digitalized community elderly care service platform.
Health Management
Tongze (Beijing) Chinese Medicine Clinic under the control of Zhaotai Group is the sole institution established as the "Expert Base of Beijing Mingyi Dadian", which offers professional TCM diagnosis and treatment services.
